Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice. 2015

Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
Department of Anatomy and Histology & Embryology, Shanghai Medical College of Fudan University, Shanghai, P. R. China.

Immunosenescence contributes to pathogenesis of Alzheimer's disease (AD) in the elderly. In this study, we explored the effects of young wild type (WT) splenocytes (ySCs) on Alzheimer's disease by transplanting ySCs into APPswe/PSENldE9 transgenic mice. Young WT splenocytes not only prevented AD, but also improved the spatial learning and memory of APPswe/PSENldE9 transgenic mice. Young WT splenocytes enhanced Aβ clearance, decreased astrogliosis and increased systemic growth differentiation factor 11 (GDF11) levels. Splenocytes derived from old AD mouse promoted AD. There was an increased number of regulatory T cells (Tregs) among old AD splenocytes. We suggest that alterations of GDF11 and Tregs are involved in AD progression and that rejuvenation of the immune system is a potential therapeutic strategy in AD.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068884 Immunosenescence The decline in the function of the IMMUNE SYSTEM during aging.
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001253 Astrocytes A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. Astroglia,Astroglia Cells,Astroglial Cells,Astrocyte,Astroglia Cell,Astroglial Cell,Astroglias,Cell, Astroglia,Cell, Astroglial

Related Publications

Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
April 2010, Journal of neuroscience research,
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
April 2010, Neurobiology of disease,
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
August 2016, Age (Dordrecht, Netherlands),
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
June 2012, Sheng li ke xue jin zhan [Progress in physiology],
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
March 2008, Neurobiology of aging,
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
November 1992, Annals of the New York Academy of Sciences,
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
April 2007, Behavioral neuroscience,
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
June 2004, Comparative medicine,
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
November 2007, Neuroreport,
Fei Wang, and Xueyan Shen, and Shuping Li, and Long Chen, and Yanru Wang, and Jie Qin, and Guomin Zhou, and Yuwen Peng, and Xiaoyuan Feng, and Ruixi Li, and Chunmin Liang
December 2004, Behavioral neuroscience,
Copied contents to your clipboard!